Occupancy of dopamine D₁, D₂ and serotonin_2A receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol

By Reimold M.   Solbach C.   Noda S.   Schaefer J.-E.   Bartels M.   Beneke M.   Machulla H.-J.   Bares R.   Glaser T.   Wormstall H.  

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 241-249

Springer Publishing Company

Access to resources Recommend Favorite

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

By Gunes Arzu   Scordo Maria   Jaanson Peeter   Dahl Marja-Liisa  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 479-484

Springer Publishing Company

Access to resources Recommend Favorite

Effect of daily dosing duration of direct and indirect dopamine receptor agonists: cocaine cross-tolerance following chronic regimens

By Ellinwood E.H.   Davidson C.   Yu G.-Z.   King G.R.   Lee T.H.  

European Neuropsychopharmacology, Vol. 12, Iss. 5, 2002-10 ,pp. : 407-415

Elsevier

Access to resources Recommend Favorite

Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

By Scharfetter J.   Chaudhry H.R.   Hornik K.   Fuchs K.   Sieghart W.   Kasper S.   Aschauer H.N.  

European Neuropsychopharmacology, Vol. 10, Iss. 1, 1999-12 ,pp. : 17-20

Elsevier

Access to resources Recommend Favorite

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 156-165

Bentham Science Publishers

Access to resources Recommend Favorite